Praxis Precision Medicines, Inc. surged 35% after EMBOLD study success and strong pipeline progress, reaching its highest valuation since early 2022. PRAX's relutrigine and ulixacaltamide both ...
The Magnificent Seven represent 34.3% of the S&P 500 as of December 2025, up from 12.3% in 2015. From 2015 to 2024, these seven companies achieved a 697.6% return, outperforming the S&P 500. The S&P ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Hosted on MSN
The S&P 500 could hit 7,000 this week, while Trump hints at a Fed chair pick and Washington eyes a special election
The stock market is about to begin the final month of 2025 on the back of a strong uptrend that has raised hopes the typical year-end “Santa Claus rally” is starting early this season. Meanwhile, the ...
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. David Kindness is a Certified Public Accountant (CPA) and an expert in the fields of ...
A difficult third-quarter stretch not only squandered the Panthers a chance at a win — but also an early berth into the playoffs. Part of the McClatchy Media Network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback